Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.895
BATS BZX Real-Time Price
As of 1:09pm ET
 +0.0249 / +2.86%
Today’s Change
0.80
Today|||52-Week Range
3.50
-28.97%
Year-to-Date
No recent news for Aveo Pharmaceuticals Inc.

Today’s Trading

Previous close0.87
Today’s open0.86
Day’s range0.82 - 0.90
Volume139,099
Average volume (3 months)499,125
Market cap$50.6M
Dividend yield--
Data as of 1:09pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)+51.90%
Earnings growth (this year)+81.19%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,301.62%
P/E ratioNM
Price/Sales2.42
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd-0.02-2.00%
--Synergy CHC Corp0.000.00%
SBOTStellar Biotechnolog...-0.32-5.64%
IPCIIntelliPharmaCeutics...-0.00-0.00%
Data as of 12:53pm ET, 02/11/2016

Financials

Last reporting dateFebruary 11, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$18.1M
Annual profit (last year)-$52.7M
Net profit margin-291.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers